Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Novartis, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars. Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries. At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
This report elaborates on the current development of the Biosimilar Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novartis
Eli Lilly
CP Guojian Pharma
Amgen
Biotech Pharma
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection
Tablets
Other Types
Application:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biosimilar Drug Industry Overview
-
1.1.1 Biosimilar Drug Market Scope and Market Segments
-
1.1.2 Biosimilar Drug Industry Characteristics
-
1.1.3 Global and China Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biosimilar Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Biosimilar Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection
-
1.2.2 Tablets
-
1.2.3 Other Types
-
1.3 Global Biosimilar Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Ankylosing Spondylitis
-
1.3.2 Tumor
-
1.3.3 Rheumatoid Arthrtis
-
1.3.4 Cardiovascular
-
1.3.5 Other Application
-
1.4 Market Analysis by Region
-
1.4.1 North America Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biosimilar Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biosimilar Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biosimilar Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biosimilar Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biosimilar Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biosimilar Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Biosimilar Drug Industry PEST Analysis
-
2.3 Biosimilar Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biosimilar Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biosimilar Drug Industry
Chapter 3 Global and China Biosimilar Drug Market, by Manufacturer
-
3.1 Global and China Biosimilar Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biosimilar Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biosimilar Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biosimilar Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biosimilar Drug Market Top 3 Players
Chapter 4 Global and China Biosimilar Drug Market, by Type (2017-2028)
-
4.1 Biosimilar Drug Market Trend, by Type
-
4.2 Global Biosimilar Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biosimilar Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biosimilar Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biosimilar Drug Price Trend, by Type (2017-2028)
-
4.3 China Biosimilar Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biosimilar Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biosimilar Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biosimilar Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biosimilar Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biosimilar Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biosimilar Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biosimilar Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biosimilar Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biosimilar Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biosimilar Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biosimilar Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biosimilar Drug Market Analysis
-
7.1 North America Biosimilar Drug Market, by Type
-
7.2 North America Biosimilar Drug Market, by Application
-
7.3 North America Biosimilar Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biosimilar Drug Market Analysis
-
8.1 Europe Biosimilar Drug Market, by Type
-
8.2 Europe Biosimilar Drug Market, by Application
-
8.3 Europe Biosimilar Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biosimilar Drug Market Analysis
-
9.1 APAC Biosimilar Drug Market, by Type
-
9.2 APAC Biosimilar Drug Market, by Application
-
9.3 APAC Biosimilar Drug Market Analysis and Forecast, by Country
-
9.3.1 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biosimilar Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Biosimilar Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Biosimilar Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Biosimilar Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biosimilar Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biosimilar Drug Company Profiles
-
11.1 Novartis
-
11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novartis Biosimilar Drug Product Profiles, Application and Specification
-
11.1.3 Novartis Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Eli Lilly Biosimilar Drug Product Profiles, Application and Specification
-
11.2.3 Eli Lilly Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 CP Guojian Pharma
-
11.3.1 CP Guojian Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 CP Guojian Pharma Biosimilar Drug Product Profiles, Application and Specification
-
11.3.3 CP Guojian Pharma Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Amgen
-
11.4.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Amgen Biosimilar Drug Product Profiles, Application and Specification
-
11.4.3 Amgen Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Biotech Pharma
-
11.5.1 Biotech Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Biotech Pharma Biosimilar Drug Product Profiles, Application and Specification
-
11.5.3 Biotech Pharma Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biosimilar Drug Industry Investment Prospect and Risk Assessment
-
12.1 Biosimilar Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biosimilar Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biosimilar Drug Production Value and Growth Rate (2017-2028)
-
Figure China Biosimilar Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Tablets (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Other Types (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Tumor (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Cardiovascular (2017-2028)
-
Figure Global Biosimilar Drug Market Size and Growth Rate of Other Application (2017-2028)
-
Figure North America Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biosimilar Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biosimilar Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biosimilar Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biosimilar Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Biosimilar Drug Market Share, by Manufacturer in 2022
-
Table Global Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table Global Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Biosimilar Drug Sales Value, by Type (2017-2028)
-
Table Global Biosimilar Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Biosimilar Drug Price Trend, by Type (2017-2028)
-
Table China Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table China Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table China Biosimilar Drug Sales Value, by Type (2017-2028)
-
Table China Biosimilar Drug Sales Value Share, by Type (2017-2028)
-
Figure China Biosimilar Drug Price Trend, by Type (2017-2028)
-
Table Global Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table Global Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Biosimilar Drug Sales Value, by Application (2017-2028)
-
Table Global Biosimilar Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Biosimilar Drug Sales Value Share, by Application (2017-2028)
-
Table China Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table China Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Table China Biosimilar Drug Sales Value, by Application (2017-2028)
-
Table China Biosimilar Drug Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Drug Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biosimilar Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table North America Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table North America Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table Europe Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table Europe Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table APAC Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table APAC Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Drug Sales Value and Growth Rate (2017-2028)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CP Guojian Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CP Guojian Pharma Product Profiles, Application and Specification
-
Table CP Guojian Pharma Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biotech Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biotech Pharma Product Profiles, Application and Specification
-
Table Biotech Pharma Biosimilar Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
